BCR-ABL kinase activity has been found to increase intracellular ROS levels, which is significantly more pronounced in CML-BP cells, exhibiting higher BCR-ABL levels than in CP CML cells19. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.